New York City, NY (PRWEB) December 07, 2013
A new Tylenol lawsuit (http://www.tylenollawsuitclaims.com/) website has been launched by Bernstein Liebhard LLP to keep the public informed regarding the ongoing litigation of product liability claims that allege an association between the use of Tylenol and liver damage. The new website will provide consumers with updates on the most recent developments in the Tylenol litigation underway in Pennsylvania Federal Court, and will also enable alleged victims of Tylenol liver damage to obtain free legal evaluations from the Firms attorneys.
Tylenol products are so ubiquitous in U.S. households, and many consumers are not aware that these over-the-counter products pose some very real risks. Our Firms website will provide individuals who were allegedly harmed by Tylenol with comprehensive information regarding their legal rights, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is offering free Tylenol lawsuit reviews to victims of severe liver damage allegedly associated with the use of Tylenol-brand medications.
According to data from the U.S. Food & Drug Administration (FDA), acetaminophen, the active ingredient in Tylenol products, was the leading cause of acute liver failure in the U.S. between 1998 and 2003. From 1990 to 1998, the ingredient was cited as the cause of 56,000 emergency room visits, 26,000 hospitalizations, and 458 deaths annually.
This past summer, Johnson & Johnson announced it would be adding more prominent warnings to the labels of Tylenol products regarding the potential for liver damage. According to a report from Bloomberg.com, the red-lettered warnings began appearing on bottles of Extra Strength Tylenol in October. Two years ago, the FDA mandated that prescription medications could only contain 325 milligrams of acetaminophen per two pills. However, Extra Strength Tylenol each contain 500 milligrams, according to Bloomberg.com.*
Court documents indicate that around 100 Tylenol lawsuits have been filed in a multidistrict litigation underway in U.S. District Court, Eastern District of Pennsylvania. All of the claims pending in the litigation accuse Johnson & Johnson of failing to provide consumers with adequate warnings regarding the association between Tylenol and liver damage. According to an order issued by the Court in October, the selection of individual Tylenol lawsuits as possible candidates for the proceedings first bellwether trials will conclude by April 2014. (In Re: Tylenol (Acetaminophen) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2436)
Victims of severe liver damage resulting in hospitalization, liver transplantation or death allegedly caused by Tylenol may be entitled to compensation for medical bills, lost wages, pain and suffering and more. To learn more about filing a Tylenol lawsuit, please visit Bernstein Liebhard LLPs website. For a free evaluation of your claim, please call 800-511-5092.
*bloomberg.com/news/2013-08-29/j-j-adds-warning-to-tylenol-caps-on-acetaminophen-risk.html, Bloomberg.com, August 29, 2013
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 11 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016